However, miR-1290 counteracts the tumor-suppressive effects of CDR1 by modulating the expression of apoptosis-related factors, including Bcl-2, Bax, and caspase-3, and facilitating tumor spread (Kim et al., 2014). The gene discussed is BAX; the disease is neoplasm.